← The frontier
Technology & AIAug 6, 2026

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.